A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Abbott Laboratories stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 914,635 shares of ABT stock, worth $119 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
914,635
Previous 225,996 304.71%
Holding current value
$119 Million
Previous $25.8 Million 301.53%
% of portfolio
1.09%
Previous 0.26%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$111.93 - $119.39 $77.1 Million - $82.2 Million
688,639 Added 304.71%
914,635 $103 Million
Q3 2024

Nov 08, 2024

BUY
$100.07 - $118.13 $9.65 Million - $11.4 Million
96,421 Added 74.41%
225,996 $25.8 Million
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $465,775 - $519,922
-4,624 Reduced 3.45%
129,575 $13.5 Million
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $332,612 - $367,355
-3,037 Reduced 2.21%
134,199 $15.3 Million
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $4.6 Million - $5.63 Million
51,018 Added 59.17%
137,236 $15.1 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $8,024 - $9,628
84 Added 0.1%
86,218 $8.35 Million
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $542,297 - $604,232
5,381 Added 6.66%
86,134 $9.39 Million
Q1 2023

May 10, 2023

SELL
$96.86 - $114.01 $180,837 - $212,856
-1,867 Reduced 2.26%
80,753 $8.18 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $450,489 - $528,493
4,739 Added 6.08%
82,620 $9.07 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $731,795 - $847,282
-7,563 Reduced 8.85%
77,881 $7.54 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $1.87 Million - $2.26 Million
-18,308 Reduced 17.65%
85,444 $9.28 Million
Q1 2022

May 10, 2022

BUY
$114.02 - $139.04 $419,593 - $511,667
3,680 Added 3.68%
103,752 $12.3 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $11.6 Million - $14.2 Million
100,072 New
100,072 $14.1 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $229B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.